{"id":517279,"date":"2021-07-26T06:53:08","date_gmt":"2021-07-26T10:53:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/"},"modified":"2021-07-26T06:53:08","modified_gmt":"2021-07-26T10:53:08","slug":"therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/","title":{"rendered":"TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021"},"content":{"rendered":"

<\/p>\n

TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021<\/b><\/p>\n

\n-Executive Management to Host Conference Call on August 4, 2021 at 8:30 a.m. ET-\n<\/p>\n

BOCA RATON, Fla.–(BUSINESS WIRE<\/a>)–
\nTherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women\u2019s healthcare company, today announced that it will report its second quarter 2021 financial results on Wednesday, August 4, 2021, before the opening of the U.S. financial markets. Following the announcement, executive management will host a conference call and webcast at 8:30 a.m. ET to discuss the Company\u2019s financial results and provide a business update.\n<\/p>\n

Conference Call & Audio Webcast Details<\/b><\/p>\n\n\n\n\n\n\n\n
\n

\nDate\n<\/p>\n<\/td>\n

\n

\nWednesday, August 4, 2021\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTime\n<\/p>\n<\/td>\n

\n

\n8:30 a.m. ET\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTelephone Access: U.S. and Canada\n<\/p>\n<\/td>\n

\n

\n866-665-9531\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nTelephone Access: International\n<\/p>\n<\/td>\n

\n

\n724-987-6977\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAccess Code For All Callers\n<\/p>\n<\/td>\n

\n

\n7736027\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nLive Audio Webcast\n<\/p>\n<\/td>\n

\n

www.therapeuticsmd.com
\n<\/a>
See Home Page or \u201cInvestors & Media\u201d Section\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nA live webcast and audio archive for the event may be accessed on the home page or from the \u201cInvestors & Media\u201d section of the TherapeuticsMD website at www.therapeuticsmd.com<\/a>. Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast will be archived on the website for at least 30 days. In addition, a digital recording of the conference call will be available for replay beginning two hours after the call’s completion and for at least 30 days with the dial-in 855-859-2056 or international 404-537-3406 and Conference ID: 7736027.\n<\/p>\n

About TherapeuticsMD<\/b><\/p>\n

\nTherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. The company is committed to advancing the health of women and championing awareness of their healthcare issues. To learn more about TherapeuticsMD, please visit therapeuticsmd.com<\/a> or follow us on Twitter: @TherapeuticsMD and on Facebook: TherapeuticsMD.\n<\/p>\n

Forward Looking Statements <\/b><\/p>\n

\nThis press release by TherapeuticsMD, Inc. may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to TherapeuticsMD\u2019s objectives, plans and strategies as well as statements, other than historical facts, that address activities, events or developments that the company intends, expects, projects, believes or anticipates will or may occur in the future. These statements are often characterized by terminology such as “believes,” “hopes,” “may,” “anticipates,” “should,” “intends,” “plans,” “will,” “expects,” “estimates,” “projects,” “positioned,” “strategy” and similar expressions and are based on assumptions and assessments made in light of management\u2019s experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and the company undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, many of which are outside of the company\u2019s control. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the sections titled “Risk Factors” in the company\u2019s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as well as reports on Form 8-K, and include the following: the effects of the COVID-19 pandemic; the company\u2019s ability to maintain or increase sales of its products; the company\u2019s ability to develop and commercialize IMVEXXY\u00ae, ANNOVERA\u00ae, and BIJUVA\u00ae and obtain additional financing necessary therefor; whether the company will be able to comply with the covenants and conditions under its term loan facility; whether the company will be able to successfully divest its vitaCare business and the proceeds that may be generated by such divestiture; the potential of adverse side effects or other safety risks that could adversely affect the commercialization of the company\u2019s current or future approved products or preclude the approval of the company\u2019s future drug candidates; whether the FDA will approve the lower dose of BIJUVA; the company\u2019s ability to protect its intellectual property, including with respect to the Paragraph IV notice letters the company received regarding IMVEXXY and BIJUVA; the length, cost and uncertain results of future clinical trials; the company\u2019s reliance on third parties to conduct its manufacturing, research and development and clinical trials; the ability of the company\u2019s licensees to commercialize and distribute the company\u2019s products; the ability of the company\u2019s marketing contractors to market ANNOVERA; the availability of reimbursement from government authorities and health insurance companies for the company\u2019s products; the impact of product liability lawsuits; the influence of extensive and costly government regulation; the volatility of the trading price of the company\u2019s common stock and the concentration of power in its stock ownership.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210726005174\/en\/<\/a><\/span><\/p>\n

Investor Contact
\n<\/b>
In-Site Communications, Inc.
\n
Lisa M. Wilson
\n
212-452-2793
\n
lwilson@insitecony.com<\/a><\/p>\n

Media Contact
\n<\/b>
Kristen Landon
\n
Vice President, Marketing and Corporate Communications
\n
561-961-1900
\n
Klandon@therapeuticsmd.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America Florida<\/p>\n

INDUSTRY KEYWORDS:<\/b> Health Consumer Women Baby\/Maternity General Health Pharmaceutical<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021 -Executive Management to Host Conference Call on August 4, 2021 at 8:30 a.m. ET- BOCA RATON, Fla.–(BUSINESS WIRE)– TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women\u2019s healthcare company, today announced that it will report its second quarter 2021 financial results on Wednesday, August 4, 2021, before the opening of the U.S. financial markets. Following the announcement, executive management will host a conference call and webcast at 8:30 a.m. ET to discuss the Company\u2019s financial results and provide a business update. Conference Call & Audio Webcast Details Date Wednesday, August 4, 2021 Time 8:30 a.m. ET Telephone Access: U.S. and Canada 866-665-9531 Telephone Access: International 724-987-6977 Access Code For All … <\/p>\n

Continue reading “TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-517279","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021 -Executive Management to Host Conference Call on August 4, 2021 at 8:30 a.m. ET- BOCA RATON, Fla.–(BUSINESS WIRE)– TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women\u2019s healthcare company, today announced that it will report its second quarter 2021 financial results on Wednesday, August 4, 2021, before the opening of the U.S. financial markets. Following the announcement, executive management will host a conference call and webcast at 8:30 a.m. ET to discuss the Company\u2019s financial results and provide a business update. Conference Call & Audio Webcast Details Date Wednesday, August 4, 2021 Time 8:30 a.m. ET Telephone Access: U.S. and Canada 866-665-9531 Telephone Access: International 724-987-6977 Access Code For All … Continue reading "TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-26T10:53:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210726005174r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021\",\"datePublished\":\"2021-07-26T10:53:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\\\/\"},\"wordCount\":897,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210726005174r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\\\/\",\"name\":\"TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210726005174r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-07-26T10:53:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210726005174r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210726005174r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/","og_locale":"en_US","og_type":"article","og_title":"TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021 - Market Newsdesk","og_description":"TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021 -Executive Management to Host Conference Call on August 4, 2021 at 8:30 a.m. ET- BOCA RATON, Fla.–(BUSINESS WIRE)– TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women\u2019s healthcare company, today announced that it will report its second quarter 2021 financial results on Wednesday, August 4, 2021, before the opening of the U.S. financial markets. Following the announcement, executive management will host a conference call and webcast at 8:30 a.m. ET to discuss the Company\u2019s financial results and provide a business update. Conference Call & Audio Webcast Details Date Wednesday, August 4, 2021 Time 8:30 a.m. ET Telephone Access: U.S. and Canada 866-665-9531 Telephone Access: International 724-987-6977 Access Code For All … Continue reading \"TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-26T10:53:08+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210726005174r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021","datePublished":"2021-07-26T10:53:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/"},"wordCount":897,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210726005174r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/","name":"TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210726005174r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-07-26T10:53:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210726005174r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210726005174r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-to-report-second-quarter-2021-results-on-august-4-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=517279"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517279\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=517279"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=517279"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=517279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}